This compound is a chiral pharmaceutical intermediate featuring a fused cyclopenta[b]furan ring system with a tert-butyldimethylsilyl ether protecting group. It is primarily significant as a key synthetic building block in the preparation of prostaglandins.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 64072-25-9
(3aR,4R,5R,6aS)-5-((tert-Butyldimethylsilyl)oxy)-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one
Prostaglandin intermediate
(1,1'-Biphenyl)-4-carboxylic acid, (3aR,4S,5R,6aS)-hexahydro-4-(hydroxymethyl)-2-oxo-2H-cyclopenta(b)furan-5-yl ester
Pharmaceutical intermediate for prostaglandin synthesis
Tetrahydro-2H-thiopyran-4-carboxylic acid 1,1-dioxide
pharmaceutical intermediate
2-Fluoro-5-methylbenzonitrile
Pharmaceutical intermediate
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
Nilotinib intermediate
Ethyl 3-Carbamimidoylamino-4-methylbenzoate Nitrate
pharmaceutical intermediate
(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2H-cyclopenta[b]furan-2-one
Prostaglandin research compound
(3aR,4S,5R,6aS)-hexahydro-5-hydroxy-4-(hydroxymethyl)-2H-cyclopenta[b]furan-2-one
prostaglandin synthesis intermediate
(3aR,4R,5R,6aS)-5-[tert-butyl(dimethyl)silyl]oxy-4-[(E)-3-oxooct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one
RUMJJBFTZIDROK-KXCTWPOZSA-N
CCCCCC(=O)/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=O)O2)O[Si](C)(C)C(C)(C)C
—